D-0426-2017 Class III Terminated
FDA drug recall D-0426-2017 was initiated by Pharm D Solutions, LLC on Oct 12, 2016 and is designated Class III. Reason for recall: Incorrect/Undeclared Excipient; product description section of testosterone cypionate incorrectly states "in grapeseed oil" instead of "in sesame oil" . The primary panel is correct The recall status is terminated (terminated May 11, 2017). Affected quantity: 4 mL: 510 vials, 5 mL: 486 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 18, 2017
- Initiation Date
- Oct 12, 2016
- Termination Date
- May 11, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4 mL: 510 vials, 5 mL: 486 vials
Product description
Testosterone Cypionate 200 mg/mL in Sesame Oil, 4 mL and 5 mL vials, Rx only, For IM injection, Pharm D Solutions, Loop West Houston, TX --- NDA 69699-1709-04
Reason for recall
Incorrect/Undeclared Excipient; product description section of testosterone cypionate incorrectly states "in grapeseed oil" instead of "in sesame oil" . The primary panel is correct
Distribution pattern
AZ and WA
Code information
Lot: 09122016:34, exp 09/07/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0426-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026